All companies
Visit website
Kationx
OperatingKationx Corp
Biotech · Founded 2019
Kationx products fix problems for an expanding range of industrial and commercial markets. We are a fast-growing, materials sciences company that develops, manufactures, and distributes our own proprietary, environmentally safe, cleantech products for customers including the wastewater treatment and horizontal directional drilling industries. Kationx improves the environment and regulatory compliance while working to reduce costs and risks.
Post-money valuation ⓘ
$16.2M
As of Jul 2021 · from Kationx Stock 1 · pre-money + amount raised, not a traded price
Total raised
$250,129
Across 1 round since 2020
Latest share price
$0.72
Kationx Stock 1 offering price
Financials
FY2018–FY2020 · from SEC filings · hover any figure for its source$7K
−$172K
2018
$12K
−$784K
2019
$78K
−$767K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
Income statement
Revenue
$6,740
$11,880
$78,172
Cost of goods sold
$1,685
$49,481
$19,544
Gross margin
75%
-317%
75%
Net income
-$171,740
-$784,002
-$766,929
Taxes paid
$0
$545
$0
Balance sheet
Cash
$11,027
$11,027
$16,967
Accounts receivable
$0
$0
$19,281
Total assets
$163,921
$170,173
$117,628
Short-term debt
$94,900
$263,798
$401,512
Long-term debt
$220,760
$254,084
$0
Total liabilities
$315,660
$517,882
$401,512
Other
Headcount
—
13
13
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$16.2M
post-money
Kationx Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $250.1K / $1.1MInvestors 401Post-money $16.2M
Reg CF annual-report compliance
Delinquent
Filed 1 of 6 annual reports (FY2020–FY2025)
Missing: 2021, 2022, 2023, 2024, 2025
401 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001831843Share price $0.72
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.